查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1454118

重組抗體市場，按類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Recombinant Antibodies Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年重組抗體市場規模為 121.1 億美元，2024 年至 2032 年CAGR為 6.5%。

重組抗體市場-市場動態

癌症和傳染病病例的增加推動市場成長

在預測期內，由於全球傳染病和癌症病例發生率上升，重組抗體市場預計將成長。透過識別並附著在癌細胞表面表達的抗原，重組抗體被設計為精確靶向癌細胞。與傳統化療相比，這種集中的方法減少了副作用並減少了對健康細胞的傷害。這也可用於被動免疫，提供針對傳染性病原體的即時防禦。它們可以提供給那些處於危險中或已經受到感染的人，例如在某些病毒流行的情況下，因為它們的設計類似於免疫反應。例如，根據全球癌症觀測站 (GLOBOCAN) 的估計，2020 年全球將有 1,930 萬例癌症病例。印度排名第三，僅次於美國和中國。 2040年，印度將新發現208萬例癌症病例，比2020年增加57.5%。

重組抗體市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 6.5% 左右的CAGR成長

根據類型細分，單鏈抗體細分市場預計將在預測期內佔據最大的收入佔有率

根據應用細分，製藥和生物技術領域預計將在預測期內主導市場

從地區來看，預計北美將在預測期內主導市場

重組抗體市場-細分分析：

全球重組抗體市場根據類型、應用和地區進行細分。

依類型，重組抗體市場分為單股抗體、全人抗體、人源化抗體、嵌合抗體及雙特異性抗體。預計單鏈抗體細分市場將在預測期內佔據最大的收入佔有率。重組DNA技術用於製造單鏈抗體，能夠改變結合特異性和親和力。這一特性提高了它們針對與一系列疾病相關的特定抗原的適應性。由於 scFv 分子比典型抗體更小、結構更簡單，因此在某些情況下很有用。較小的尺寸可以實現更大的組織穿透力，這可能會帶來更好的治療效果。

根據應用，全球重組抗體市場分為醫院和診斷實驗室、製藥和生物技術、研究機構等。預計製藥和生物技術領域將在預測期內主導市場。主要製藥和生技公司大力投資重組抗體相關的研發活動。因此，推動了細分市場的擴張。

重組抗體市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。區域市場的擴張歸因於主要參與者的存在。此外，癌症和其他傳染病患者的上升極大地推動了該地區的市場成長。

重組抗體市場-競爭格局：

市場的主要參與者包括 Bio-Rad Laboratories、GE Healthcare、F. Hoffmann-La Roche、BIOLEGEND、BD Biosciences、Creative Biolabs、Merck KGaA、Abnova、Abcam、SinoBiological、BBI Solutions、ProMab Biotechnologies 和 Beckman Coulter。這些參與者採取了各種策略來獲得行業的主要市場佔有率，包括產品發布、收購、合作等。

最近的發展：

2023 年 11 月，Lonza 宣布啟用其新的 GS Effex(R)細胞株，以促進更有效的治療抗體的生產。 GS Effex(R)細胞株是為了響應更先進的治療性抗體的發展而帶來的迫切市場需求而創建的。 GS Effex(R) 源自 Lonza 性能最佳的 GS Xceed(R)細胞株，與 Lonza 平台完美整合。當與強勁的細胞生長和產生有效治療抗體的能力相結合時，這種獨特的細胞株為從早期研究到商業生產的治療開發提供了解決方案。

目錄

第1章：重組抗體市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的重組抗體市場片段
    • 重組抗體市場片段（依應用）
    • 按國家/地區分類的重組抗體市場片段
    • 按地區分類的重組抗體市場片段
  • 競爭洞察

第 3 章：重組抗體主要市場趨勢

  • 重組抗體市場促進因素
    • 市場促進因素的影響分析
  • 重組抗體市場限制
    • 市場限制影響分析
  • 重組抗體市場機會
  • 重組抗體市場未來趨勢

第 4 章：重組抗體產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：重組抗體市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：重組抗體市場格局

  • 2023 年重組抗體市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：重組抗體市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 單股抗體
    • 全人源抗體
    • 人源化抗體
    • 嵌合抗體
    • 雙特異性抗體

第 8 章：重組抗體市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 醫院和診斷實驗室
    • 製藥與生物技術
    • 研究機構
    • 其他

第 9 章：重組抗體市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美重組抗體主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲重組抗體主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區重組抗體主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲重組抗體主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲重組抗體主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 重組抗體產業

  • 競爭儀表板
  • 公司簡介
    • Bio-Rad Laboratories
    • GE Healthcare
    • F. Hoffmann-La Roche
    • BIOLEGEND
    • BD Biosciences
    • Creative Biolabs
    • Merck KGaA
    • Abnova
    • Abcam
    • SinoBiological
    • BBI Solutions
    • ProMab Biotechnologies
    • Beckman Coulter

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2299

REPORT HIGHLIGHT

Recombinant Antibodies Market size was valued at USD 12,110 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Synthetic monoclonal antibodies, or recombinant antibodies, are created in vitro using recombinant DNA technology as a substitute for the traditional hybridoma-based approach of manufacturing monoclonal antibodies. Recombinant antibodies may be created without vaccinating animals since synthetic genes are employed to make them outside of the immune system. These synthetic antibodies are superior to traditional animal-derived antibodies in a number of respects and may be used in any application due to their high specificity, sensitivity, and repeatability.

Recombinant Antibodies Market- Market Dynamics

Increasing cases of cancer and infectious disease drives market growth

Over the projected period, the market for recombinant antibodies is anticipated to grow as a result of the rising incidence of infectious diseases and cancer cases worldwide. By identifying and attaching to antigens expressed on the surface of cancer cells, recombinant antibodies are engineered to precisely target cells that are cancerous. Compared to conventional chemotherapy, this focused approach reduces adverse effects and decreases harm to healthy cells. This may also be used to passive immunization, which offers instant defense against infectious pathogens. They can be given to those who are at danger or have been exposed to infections, such as in the event of certain viral epidemics, since they are made to resemble the immune response. For instance, according to estimates from the Global Cancer Observatory (GLOBOCAN), there will be 19.3 million incident cases of cancer globally in 2020. India placed third, behind the United States of America and China. 2.08 million new cases of cancer would be detected in India in 2040, up 57.5 percent from 2020.

Recombinant Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on type segmentation, the Single Chain Antibody segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Recombinant Antibodies Market- Segmentation Analysis:

The Global Recombinant Antibodies Market is segmented based on Type, Application and Region.

Based on the type, the Recombinant Antibodies market is bifurcated into Single Chain Antibody, Full Human Antibody, Humanized Antibody, Chimeric Antibody and Bispecific Antibody. The Single Chain Antibody segment is expected to capture the largest revenue share over the projected period. Recombinant DNA technology is used to manufacture single chain antibodies, enabling the modification of binding specificity and affinity. This characteristic increases their adaptability in focusing on particular antigens associated with a range of illnesses. Because of their smaller size and simpler structure than typical antibodies, scFv molecules are useful in some situations. greater tissue penetration may be made possible by their lower size, which might lead to greater therapeutic results.

Based on the application, the global Recombinant Antibodies market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes and Others. The Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period. Major pharmaceutical and biotechnology companies invest heavily in research and development activities related to recombinant antibodies. Thus, driving the segment expansion.

Recombinant Antibodies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The regional market expansion is attributed to the presence of major players. Additionally, the rising prevalence of cancer and others infectious disease significantly drive the market growth in the region.

Recombinant Antibodies Market- Competitive Landscape:

The key players operating in the market are Bio-Rad Laboratories, GE Healthcare, F. Hoffmann-La Roche, BIOLEGEND, BD Biosciences, Creative Biolabs, Merck KGaA, Abnova, Abcam, SinoBiological, BBI Solutions, ProMab Biotechnologies and Beckman Coulter. These players adopted various strategies to gain major market share in the industry including product launch, acquisition, collaboration and others.

Recent Developments:

In November 2023, Lonza declared the opening of its new GS Effex(R) cell line to facilitate the production of more potent therapeutic antibodies. The GS Effex(R) cell line was created in response to urgent market demands brought on by the move toward more advanced therapeutic antibodies. GS Effex(R), which is derived from Lonza's top-performing GS Xceed(R) cell line, integrates well with Lonza platforms. When coupled with robust cell growth and the capacity to generate potent therapeutic antibodies, this unique cell line offers a solution for therapeutic development spanning from early-stage research to commercial manufacture.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT ANTIBODIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bio-Rad Laboratories

GE Healthcare

F. Hoffmann-La Roche

BIOLEGEND

BD Biosciences

Creative Biolabs

Merck KGaA

Abnova

Abcam

SinoBiological

BBI Solutions

ProMab Biotechnologies

Beckman Coulter

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Single Chain Antibody
  • Full Human Antibody
  • Humanized Antibody
  • Chimeric Antibody
  • Bispecific Antibody

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology
  • Research Institutes
  • Others

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Recombinant Antibodies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Recombinant Antibodies Market Snippet by Type
    • 2.1.2.Recombinant Antibodies Market Snippet by Application
    • 2.1.3.Recombinant Antibodies Market Snippet by Country
    • 2.1.4.Recombinant Antibodies Market Snippet by Region
  • 2.2.Competitive Insights

3.Recombinant Antibodies Key Market Trends

  • 3.1.Recombinant Antibodies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Recombinant Antibodies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Recombinant Antibodies Market Opportunities
  • 3.4.Recombinant Antibodies Market Future Trends

4.Recombinant Antibodies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Recombinant Antibodies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Recombinant Antibodies Market Landscape

  • 6.1.Recombinant Antibodies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Recombinant Antibodies Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Single Chain Antibody
    • 7.1.3.Full Human Antibody
    • 7.1.4.Humanized Antibody
    • 7.1.5.Chimeric Antibody
    • 7.1.6.Bispecific Antibody

8.Recombinant Antibodies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hospitals & Diagnostic Laboratories
    • 8.1.3.Pharmaceutical & Biotechnology
    • 8.1.4.Research Institutes
    • 8.1.5.Others

9.Recombinant Antibodies Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Recombinant Antibodies Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Recombinant Antibodies Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Recombinant Antibodies Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Recombinant Antibodies Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Recombinant Antibodies Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Recombinant Antibodies Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bio-Rad Laboratories
    • 10.2.2.GE Healthcare
    • 10.2.3.F. Hoffmann-La Roche
    • 10.2.4.BIOLEGEND
    • 10.2.5.BD Biosciences
    • 10.2.6.Creative Biolabs
    • 10.2.7.Merck KGaA
    • 10.2.8.Abnova
    • 10.2.9.Abcam
    • 10.2.10.SinoBiological
    • 10.2.11.BBI Solutions
    • 10.2.12.ProMab Biotechnologies
    • 10.2.13.Beckman Coulter

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Recombinant Antibodies Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Recombinant Antibodies Market, by Type 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Recombinant Antibodies Market, by Application 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Recombinant Antibodies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Recombinant Antibodies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Europe Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Asia Pacific Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Latin America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Middle East and Africa Recombinant Antibodies Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Germany Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE India Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Brazil Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Saudi Arabia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)